Efforts to develop an evidence-based approach to the evaluation and management of young febrile infants have spanned decades. Nonadherence to previous clinical prediction models1 as well as changing bacteriology,2 cost of unnecessary care, advances in testing, and evolving research provided the impetus for this guideline.3,4